DL-2-Haloacid dehalogenase from Pseudomonas sp. strain 113 (DL-DEX) catalyzes the hydrolytic dehalogenation of both D-and L-2-haloalkanoic acids to produce the corresponding L-and D-2-hydroxyalkanoic acids, respectively, with inversion of the C 2 configuration. DL-DEX is a unique enzyme: it acts on the chiral carbon of the substrate and uses both enantiomers as equivalent substrates. We have isolated and sequenced the gene encoding DL-DEX. The open reading frame consists of 921 bp corresponding to 307 amino acid residues. No sequence similarity between DL-DEX and L-2-haloacid dehalogenases was found. However, DL-DEX had significant sequence similarity with D-2-haloacid dehalogenase from Pseudomonas putida AJ1, which specifically acts on D-2-haloalkanoic acids: 23% of the total amino acid residues of DL-DEX are conserved. We mutated each of the 26 residues with charged and polar side chains, which are conserved between DL-DEX and D-2-haloacid dehalogenase. Thr65, Glu69, and Asp194 were found to be essential for dehalogenation of not only the D-but also the L-enantiomer of 2-haloalkanoic acids. Each of the mutant enzymes, whose activities were lower than that of the wild-type enzyme, acted on both enantiomers of 2-haloacids as equivalent substrates in the same manner as the wild-type enzyme. We also found that each enantiomer of 2-chloropropionate competitively inhibits the enzymatic dehalogenation of the other. These results suggest that DL-DEX has a single and common catalytic site for both enantiomers.
DL-2-Haloacid dehalogenase from Pseudomonas sp. strain 113 (DL-DEX) catalyzes the hydrolytic dehalogenation of both enantiomers of 2-haloalkanoic acids to produce the corresponding 2-hydroxyalkanoic acids with inversion of the C 2 configuration (14, 15) . DL-DEX is a unique enzyme; it acts on the chiral carbon of the substrate enantiomers, which are used as equivalent substrates. Most other enzymes acting on the chiral carbon of substrates act on a sole enantiomer. Racemases and DL-DEX are the exceptions, although racemases differ markedly from DL-DEX in that they catalyze stereochemical but not chemical conversion of substrates. Racemases are believed to possess a single and common binding site for both substrate enantiomers. Thus, it will be interesting to clarify whether DL-DEX has a common site or distinct ones for each enantiomer in order to compare it with racemases. Different kinds of 2-haloacid dehalogenases showing different stereospecificities have been isolated from several bacterial strains (2, 6, 21) . L-2-Haloacid dehalogenases specifically act on L-enantiomers of 2-haloacids to produce the corresponding D-2-hydroxy acids (11, 13, 23) . D-2-Haloacid dehalogenase from Pseudomonas putida AJ1 dehalogenates D-enantiomers to form L-2-hydroxy acids (22) . Although the two families of dehalogenases act on opposite enantiomers of 2-haloacids, they are similar to each other in that they act exclusively on one particular enantiomer. Thus, DL-DEX differs markedly from them in this respect, although all of them dehalogenate 2-haloacids with inversion of the C 2 configuration of the substrates.
Amino acid sequences of L-2-haloacid dehalogenases from various bacterial strains (7, 8, 16, 17, 20, 23) as well as that of D-2-haloacid dehalogenase of P. putida AJ1 (1) have been determined. Sequences of L-2-haloacid dehalogenases are highly similar to one another (36 to 70% identity) but completely different from that of D-2-haloacid dehalogenase (17) . On the other hand, little is known about sequence similarity between DL-DEX and other dehalogenases: the primary structure of DL-DEX has not been determined.
In the present study, we isolated and sequenced the gene encoding DL-DEX and compared the primary structure of DL-DEX with those of L-and D-2-haloacid dehalogenases. We found that DL-DEX has significant sequence similarity with D-2-haloacid dehalogenase but little with L-2-haloacid dehalogenase. We characterized DL-DEX further by means of sitedirected mutagenesis, chemical modification, and inhibition experiments in order to clarify whether DL-DEX has a catalytic site for the L-enantiomers of 2-haloacids other than the site for the D-enantiomers, the latter of which is possibly conserved with that of D-2-haloacid dehalogenase, or a single and common catalytic site for both enantiomers. Our studies presented here suggest that DL-DEX has a single catalytic site common to both enantiomers.
MATERIALS AND METHODS
Cultivation of the cells. Pseudomonas sp. strain 113 was grown aerobically at 30°C in a medium containing 0.3% DL-2-chloropropionate (DL-CPA), 0.5% (NH 4 ) 2 SO 4 , 0.1% KH 2 PO 4 , 0.1% Na 2 HPO 4 ⅐ 12H 2 O and 0.01% MgSO 4 ⅐ 7H 2 O (pH 7.0).
Recombinant Escherichia coli cells were cultivated at 37°C in Luria-Bertani (LB) medium (1% polypeptone, 0.5% yeast extract, and 1% NaCl) (pH 7.5) containing 100 g of ampicillin per ml. For induction of the gene under the control of the lac promoter, 1 mM isopropyl-1-thio-␤-D-galactoside (IPTG) was added to the LB medium.
Construction of a gene library and screening. DNA isolated from Pseudomonas sp. strain 113 was partially digested with Sau3AI. The fragments with mo-lecular sizes ranging between 1 and 12 kbp were isolated by electroelution after agarose gel electrophoresis. The fragments were inserted into the BamHI site of pUC118, and the resulting plasmids were introduced into E. coli XL1-Blue. The transformants were selected on LB agar plates containing ampicillin, IPTG, and X-Gal (5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside).
The gene library was screened by the bromoacetate or immunoscreening method as follows. The bromoacetate method is based on the toxicity of monobromoacetate to the host cells that do not express the dehalogenase gene. The transformants were transferred to LB broth containing 100 g of ampicillin per ml, 1 mM IPTG, and 0.3 mg of monobromoacetate per ml and cultivated. The cells were transferred again to a fresh medium of the same composition and then cultivated on agar plates of the same composition. The immunoscreening method was performed as follows. The transformant colonies were replica plated on nitrocellulose filters (Millipore) and screened with a rabbit antiserum raised against DL-DEX and a goat anti-rabbit immunoglobulin G-alkaline phosphatase conjugate as described by Sambrook et al. (19) . The positive colonies were then plated on LB agar plates containing 100 g of ampicillin per ml, 1 mM IPTG, and 0.3 mg of monobromoacetate per ml.
DNA sequencing. Plasmid p4b-1 containing an inserted DNA fragment of 1.2 kbp (see Results) was used as a sequencing template. The nucleotide sequence was determined from both strands of DNA with an Applied Biosystems 370A DNA sequencer. Synthetic primers were used.
Sequence analysis. The homology search was done by the sequence similarity searching program, Fasta (18) . The Clustal V method was used to align the sequences (3).
Enzyme and protein assay. The enzyme activity was measured by determination of chloride ions released from D-or L-CPA. The standard assay mixture contained 25 mM D-or L-CPA, 100 mM Tris-sulfate (pH 9.5), and the enzyme and was incubated at 30°C. The reaction was terminated by addition of 0.1 volume of 3 N H 2 SO 4 . Chloride ions released were determined spectrophotometrically with mercuric thiocyanate and ferric ammonium sulfate (5) . One unit of enzyme activity was defined as the amount of enzyme that catalyzes dehalogenation of 1 mol of L-CPA per min. The enzyme activities on the other halogen compounds were determined in the same manner. Protein concentration was determined with a Bio-Rad protein assay kit.
Preparation of cell extracts and purification of DL-DEX from the recombinant E. coli. The cells were cultivated at 37°C for 14 to 18 h in LB medium containing 150 g of ampicillin per ml and 0.2 mM IPTG. The cells were collected by centrifugation, suspended in 50 mM potassium phosphate buffer (pH 7.0), and disrupted by ultrasonic oscillation. The cell debris was removed by centrifugation, and the supernatant solution was dialyzed against about 1,000 volumes of the same buffer.
DL-DEX was purified from recombinant E. coli JM109 harboring p4b-1. The supernatant solution from the cell extract was brought to 40% saturation with ammonium sulfate, and the precipitate was removed by centrifugation. The supernatant solution was applied to a Butyl Toyopearl 650M column, and elution was carried out with a linear gradient from 30 to 0% saturation of ammonium sulfate in 50 mM potassium phosphate buffer (pH 7.0). The active fractions were pooled and concentrated by ultrafiltration. The final preparation of the enzyme was shown to be homogeneous by polyacrylamide gel electrophoresis in the presence of sodium lauryl sulfate according to the method of Laemmli (10) .
Site-directed mutagenesis. Plasmid p4b-1 encoding DL-DEX was mutagenized by the method of Kunkel et al. (9) . The mutant enzymes, the base changes in the relevant triplets, and the synthetic mutagenic primers used are shown in Table 1 . The synthetic oligonucleotides were purchased from either Japan Bio Service (Niiza) or Biologica (Nagoya). The substitutions were confirmed by DNA sequencing. The mutant enzymes were produced by E. coli JM109. The mutant strains were cultured in the same manner as described above. The amount of each mutant enzyme produced corresponded to about 25% of the total soluble proteins in the cell extract, as determined by polyacrylamide gel electrophoresis in the presence of sodium lauryl sulfate and protein staining with Coomassie brilliant blue R250.
Chemical modification of DL-DEX. In all modification experiments, the homogeneous preparation of the enzyme (final concentration, 0.15 mg/ml) was incubated with modification reagents at 30°C for 90 min. The buffers and the concentrations of the reagents used are shown in Table 2 . After modification, the remaining enzyme activity with both enantiomers of CPA as the substrates was measured by determination of the chloride ions released from the substrates. Nucleotide sequence accession number. The DNA sequence reported here has been submitted to the GenBank database under accession number U97030.
RESULTS
Cloning of the gene encoding DL-DEX. The gene library of Pseudomonas sp. strain 113 was constructed and screened by either the bromoacetate method or the immunoscreening method as described above. We have cloned the L-2-haloacid dehalogenase gene from Pseudomonas sp. strain YL by means of the bromoacetate method (17) . Therefore, we used this method first to clone the DL-DEX gene and obtained two positive clones from 2,000 transformants. However, none of them produced DL-DEX, and interestingly, both of them produced L-2-haloacid dehalogenase. Pseudomonas sp. strain 113 produced only DL-DEX when it was grown in various media, for example, those containing either DL-CPA or polypeptone as the sole carbon source, and we have never observed production of L-2-haloacid dehalogenase by the strain. The L-2-haloacid dehalogenase gene of Pseudomonas sp. strain 113 is probably a cryptic one which may be expressed under unknown cultivation conditions. Thus, we used the immunoscreening method and obtained from 5,000 transformants two positive clones, named 4b-1 and 5b-1, showing DL-DEX activity. The plasmids isolated from 4b-1 and 5b-1 were named p4b-1 and p5b-1, respectively. They contained insert DNAs of 1.2 and 11 kbp, respectively. Since the clone 4b-1 showed a specific activity (4.6 U/mg) about 1.8 times higher than that of 5b-1, we used p4b-1 for further studies.
Analysis of the cloned gene. The nucleotide sequence of the cloned gene revealed occurrence of a single open reading frame consisting of 921 bp and corresponding to 307 amino acid residues (Fig. 1) . The molecular weight of the putative protein was predicted to be 34,242, which is in good agreement with that of DL-DEX purified from Pseudomonas sp. strain 113 (35,000) (15) . The deduced amino acid composition also agreed with that previously reported for the purified enzyme (15) . The deduced N-terminal amino acid sequence is identical to that determined for the enzyme purified from Pseudomonas sp. strain 113, except that the initial methionine was not found in the purified enzyme. A putative Shine-Dalgarno sequence (GGAGG) was found 9 to 13 nucleotides upstream of the initiation codon, ATG. Possible Ϫ35 (TTGAAA) and Ϫ10 (TACGAT) sequences were also found in the region from Ϫ79 to Ϫ74 and the region from Ϫ57 to Ϫ52, respectively. Five out of six nucleotides of the E. coli Ϫ35 consensus sequence (TT GACA) and four out of six nucleotides of the E. coli Ϫ10 consensus sequence (TATAAT) were conserved in the sequences.
Sequence similarity with other enzymes. We found sequence similarity between DL-DEX and D-2-haloacid dehalogenase from P. putida AJ1, which specifically acts on D-2-haloalkanoic acids (1): 72 amino acid residues of DL-DEX are conserved (23.5% identity) (Fig. 2) . In particular, eight successive residues (YGNPKYLI) in the region from 115 to 122 of DL-DEX are identical to those of D-2-haloacid dehalogenase. In contrast, DL-DEX showed no sequence similarity with L-2-haloacid dehalogenases (7, 8, 16, 17, 20, 23) .
We found that another sequence of DL-2-haloacid dehalogenase, from Alcaligenes xylosoxidans subsp. xylosoxidans ABIV, has been registered in the PIR (S42024) and EMBL (X77610) databases, although the details have not yet been published. The DL-DEX sequence is similar to this sequence: among 307 amino acid residues of DL-DEX, 123 residues are conserved (40.1% identity) (Fig. 2) . Among DL-DEX, DL-2-haloacid dehalogenase from A. xylosoxidans, and D-2-haloacid dehalogenase, 44 amino acid residues are conserved.
Expression of the DL-DEX gene in E. coli, and purification and characterization of the enzyme. When the insert DNA was cut out from p4b-1 and introduced into the plasmid pUC119 so that the DL-DEX gene would be placed in the direction opposite to that of the lac promoter (the resultant plasmid is named p4b-1-rev), enzyme activity about 24% that of p4b-1 (specific activity, 7.0 U/mg) was found. This suggests that the intrinsic promoter of the DL-DEX gene from Pseudomonas sp. strain 113 functions in E. coli cells.
DL-DEX was purified with 66% yield from the cell extract of E. coli JM109 harboring p4b-1. The enzyme had a molecular weight of about 68,000 and appeared to be composed of two subunits identical in molecular weight. The substrate specificity of the recombinant enzyme was similar to that of DL-DEX purified from the original strain, Pseudomonas sp. strain 113 (15) Table 2 shows that DL-DEX was completely inactivated by the treatment with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide. Diethylpyrocarbonate and N-bromosuccinimide also caused significant inactivation of the enzyme. These results suggest that an aspartic or glutamic acid residue may play an important role in catalysis. In contrast, modification of cysteine residues with N-ethylmaleimide, p-chloromercuribenzoate, and iodoacetamide did not cause inactivation of the enzyme. (p-Amidinophenyl)methanesulfonyl fluoride, a serine modifier, did not affect the enzyme. None of these modifications changed the stereospecificity of the enzyme: each of the modified enzymes showed essentially the same activity for both enantiomers of CPA.
Chemical modification of DL-DEX.
Site-directed mutagenesis of DL-DEX. We found that 26 amino acid residues with charged or polar side chains are conserved among three dehalogenases: DL-DEX, DL-2-haloacid dehalogenase from A. xylosoxidans, and D-2-haloacid dehalogenase from P. putida (Fig. 2) . They include three aspartate (D28, D73, and D194), one asparagine (N117), three glutamate (E69, E102, and E129), one lysine (K119), four arginine (R34, R43, R76, and R134), one serine (S193), two (15) . The conserved residues are boxed. The numbers on the left are the residue numbers of each amino acid sequence. The asterisks indicate the residues which were mutagenized in this study.
threonine (T65 and T219), two tryptophan (W37 and W201), and three tyrosine residues (Y26, Y115, and Y120). S125, E161, D167, D250, T256, and N271 are also conserved among two of the three enzymes, with amino acid residues in the other replaced with similar residues (T with S, D with E, and Q with N). We replaced each of the 26 residues with another: D with N; N with D; E with Q; K with R; R, S, and T with A; and W and Y with F. The mutant genes were highly expressed in E. coli JM109 with the pUC118 vector in the same manner as the wild-type enzyme gene, and the amounts of all of the mutant enzymes produced were essentially identical to one another. Thus, the enzyme activity of each mutant, although determined with the crude extract, probably reflects its inherent catalytic ability.
Several amino acid residues, in particular T65, E69, and D194, were found to be essential for catalysis. None of the mutant enzymes at E69 (E69Q, E69D, and E69N) and at D194 (D194N, D194E, D194G, D194A, and D194S) were active. Other amino acid residues, D28, N117, Y120, T219, and D250, also are important: they were less than 10% active compared with the wild-type enzyme. However, as shown in Fig. 3 , all mutant enzymes showed essentially the same activity toward each enantiomer of CPA. Therefore, the stereospecificity of DL-DEX was not changed by site-specific substitution of the residues.
Competitive inhibition between the two enantiomers of CPA. The dehalogenations of CPA enantiomers catalyzed by DL-DEX were inhibited by the antipodes (Fig. 4) . Plots of reciprocals of initial velocities versus reciprocals of L-CPA concentrations at several fixed concentrations of D-CPA yielded a group of straight lines intersecting at the same point. Thus, D-CPA, although it is an inherent substrate of the enzyme, is a competitive inhibitor for the dehalogenation of L-CPA, with an apparent K i value of 5.0 mM (Fig. 4B) . Similarly, L-CPA is a competitive inhibitor for the dehalogenation of L-CPA, with an apparent K i value of 1.4 mM. The K i values are similar to the corresponding K m values measured in the dehalogenation.
Activity toward 2-bromo-2-methylpropionate. We found that DL-DEX acts also on 2-bromo-2-methylpropionate with another methyl group on the ␣-carbon of 2-bromopropionate as the substrate; this substrate has a kind of double-faced structure mimicking both enantiomers of 2-bromopropionate. Apparent K m and V max values for this substrate were 5.6 mM and 410 U/mg, respectively. We found also that this compound competitively inhibits the dehalogenation of both enantiomers of CPA with K i values of 5.2 and 6.5 mM for D-and L-CPA, respectively, similar to the K m value shown above.
DISCUSSION
This is the first report showing structural similarity between DL-DEX and D-2-haloacid dehalogenase from P. putida AJ1 (1), although the similarity is not so high compared with those of other cognate protein pairs. However, in the dehalogenases, successive amino acid residues in several parts of the aligned sequences are conserved. Therefore, the two proteins are probably related with each other evolutionarily. In contrast, DL-DEX, as well as D-2-haloacid dehalogenase, has sequence similarity with none of the L-2-haloacid dehalogenases isolated from various bacteria (7, 8, 16, 17, 20, 23) . One might expect that the subunit of DL-DEX, a dimer, is composed of two domains, one of which is similar to that of L-2-haloacid dehalogenase and the other of which is similar to that of L-2-haloacid dehalogenase. However, this will not be the case, because DL-DEX resembles only D-2-haloacid dehalogenase. The active site structure of DL-DEX is probably similar solely to that of D-2-haloacid dehalogenase.
We mutated each of the charged and polar amino acid residues of DL-DEX which are conserved among DL-DEX, DL-2-haloacid dehalogenase from A. xylosoxidans, and D-2-haloacid dehalogenase to probe their roles in catalysis. Replacement of D28, T65, E69, E102, N117, Y120, D194, T219, and D250 led to a significant loss of the activity toward each enantiomer of CPA in parallel. Similarly, the activities for both enantiomers were lost in parallel also by chemical modification. Moreover, each CPA enantiomer acts as the competitive inhibitor of the other. All these results suggest that DL-DEX has a single and common active site but not separate ones for each enantiomer. The single active site accommodates both enantiomers of 2-haloacids, because the enzyme does not discriminate between the alkyl group and hydrogen atom at the ␣-carbon of 2-haloacids. In fact, 2-bromo-2-methylpropionate, which mimics both enantiomers of 2-bromopropionate, serves as a substrate for DL-DEX.
Two mechanisms have been proposed for the 2-haloacid dehalogenase reactions which proceed with inversion of the C 2 configuration of the substrates (Fig. 5) . According to the mechanism shown in Fig. 5A , a carboxyl group of an acidic amino acid residue of the enzyme attacks the ␣-carbon of the substrate, producing an ester intermediate and a halide ion. Subsequently, the ester intermediate is hydrolyzed. In this reaction, an oxygen atom of the water molecule is first incorporated into the enzyme, not into the product. The reaction catalyzed by L-2-haloacid dehalogenase from Pseudomonas sp. strain YL has been clarified to proceed as shown in Fig. 5A (12) . Alternatively, a water molecule is possibly activated through the action of an aspartic or glutamic acid residue in the same manner as aspartic protease (4) , and the activated water molecule directly attacks the ␣-carbon of the substrate to displace the halogen atom (Fig. 5B) . The site-directed mutagenesis studies shown here suggest that the acidic amino acid residue, if any, participating in catalysis is probably either E69 or D194 (or both). We are studying the DL-DEX reaction by following 18 O incorporation into the product in H 2 18 O in order to compare this reaction with the L-2-haloacid dehalogenase reaction (12) . The precise active-site structure and the roles of the catalytic residues will be revealed by a crystallographic study of the enzyme, which is also being carried out. 
